Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico
Guillermo Ortí(Hospital Universitari i Politècnic La Fe), Rafael F. Duarte(Institut Català d'Oncologia), David Valcárcel(Vall d'Hebron Hospital Universitari), Ana García‐Noblejas, José R. Cabrera Marin, Jorge Sierra(Hospital de Sant Pau), Enric Carreras(Hospital Clínic de Barcelona), Valentín García‐Gutiérrez(Instituto Cajal), Jaime Sanz(Memorial Sloan Kettering Cancer Center), Ildefonso Espigado(Instituto de Biomedicina de Sevilla), Lucrecia Yáñez(Universidad de Cantabria), José M. Moraleda(Centro Regional de Hemodonación), Carlos Solano(Hospital Clínico Universitario de Valencia), Santiago Jiménez, Antònia Sampol, M J Espinosa Pascual, Manuel Jurado, Arancha Bermúdez, Christelle Ferrá(Hospital Universitari Germans Trias i Pujol), Carmen Martı́nez, Dolores Caballero, Miguel Á. Sanz(Universitat de València)
Cited by 65
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k